AGM, page-40

First 40 Last

Share
Profile

Follow
F18FDG

629 Posts.

33

29/11/17

13:44

Post #: 29216309
Share

Originally posted by Montrachet ↑

I'm not worried about any gap as I'm out of VLA for the time being. However I don't suppose its a coincidence that half of the buy depth is now set at 40c. That wasn't my doing. If I were to hazard a guess I would ask Barrett.

The problem for VLA now is that it appears that a catalyst is two years off. The company hasn't done much to dispel these feelings recently despite direct requests for them to do so. It doesn't take many holders to think they could make a few bucks in the meantime elsewhere to have a serious impact on SP.

Also I don't think the insto's will jump in to save the SP. Likely they will see it as an opportunity to accumulate.

Anyway that's why I sold. I like the company and the drug but there's a plethora out there, all struggling for patients to enrol in trials, all having to produce a mountain of data. Meanwhile the much touted Amgen's $1B bet on T-Vec hasn't turned out to be a home run for them and probably led to an increase caution for the big Pharma's before making any deals in the immuno-oncology space.

Expand

Yup. Generally recognised they paid way over the odds for a therapy with limited utility in a combo setting.

I note there have been, gradually, fewer VLA references to that deal as time has progressed and reality become more apparent.

VLA Price at posting: 63.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

First 40 Last

Add VLA (ASX) to my watchlist

AGM, page-40

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Parkes Au-Cu project to 'transform' Adavale Resources with key targets